ReviewInternational journal for equity in health2026
COVID-19 morbidity and mortality in young people in selected countries of the Americas.
Review in International journal for equity in health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWhile COVID-19 primarily affected adults, the epidemiology among adolescents and young adults has been less explored. This study describes the burden, outcomes, and correlates of COVID-19 among people aged 10-24 years in selected countries in the Americas during the acute pandemic phase (2020-mid-2022).
methodsWe analyzed case-based surveillance data reported by 32 countries and territories to the Pan American Health Organization between January 2020 and July 2022. Confirmed and probable SARS-CoV-2 infections were included following WHO definitions. We described age, sex, and temporal distributions, estimated cumulative incidence, and assessed associations between recovery status, comorbidities, and treatment modalities using logistic regression models adjusted for age and sex.
resultsA total of 17,031,217 COVID-19 cases were reported among young people (72% aged 10-19; 28% aged 20-24). Females accounted for 53% of cases. The pooled cumulative incidence was 7.7 per 100 population aged 10-24, ranging from 0.1 in Cuba to 52.0 in Bonaire, Sint Eustatius, and Saba. Recovery was documented in 88.9% of adolescents and 87.0% of young adults. The odds of recovery were lower among those aged 20-24 years (aOR 0.84, 95% CI 0.83-0.84), those with ≥ 1 comorbidity (aOR 0.17, 95% CI 0.16-0.18), and those requiring ventilatory support (aOR 0.28, 95% CI 0.25-0.31). Females and hospitalized patients had slightly higher recovery odds. Cardiovascular, kidney, and diabetic comorbidities were significantly associated with increased mortality.
conclusionsYoung people in the Americas represented a substantial proportion of COVID-19 cases, though with low overall mortality. However, chronic conditions markedly increased the risk of poor outcomes. Strengthening surveillance, ensuring continuity of care for young people with chronic diseases, and tailoring risk communication are essential components of future pandemic preparedness and life-course health strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.